The JAK2 46/1 haplotype: a marker of inappropriate myelomonocytic response to cytokine stimulation, leading to increased risk of inflammation, myeloid neoplasm, and impaired defense against infection?

Gelijkaardige items

• The JAK2 46/1 haplotype predisposes to MPL-mutated myeloproliferative neoplasms
  door: Jones, Amy V., et al.
  Gepubliceerd in: (2010)
• The JAK2 GGCC (46/1) Haplotype in Myeloproliferative Neoplasms: Causal or Random?
  door: Anelli, Luisa, et al.
  Gepubliceerd in: (2018)
• The Hepatocyte Growth Factor (HGF)/Met Axis: A Neglected Target in the Treatment of Chronic Myeloproliferative Neoplasms?
  door: Boissinot, Marjorie, et al.
  Gepubliceerd in: (2014)
• Evaluation of the association between the JAK2 46/1 haplotype and chronic myeloproliferative neoplasms in a Brazilian population
  door: Silva, Sarah Pagliarini- e-, et al.
  Gepubliceerd in: (2013)
• Genetic Pathways Leading to Therapy-Related Myeloid Neoplasms
  door: Stoddart, Angela, et al.
  Gepubliceerd in: (2011)